Posted by Incepta Pharmaceuticals Ltd.

The COVID-19 pandemic has presented challenges in management and follow-up in common respiratory diseases such as asthma. This review will discuss the current recommendations regarding asthma and COVID-19 based on best available evidence at this time. RemoveAvailable Brand
Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). It is also used before exercise to prevent breathing problems during exercise (bronchospasm).Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose).  Common Ast...